Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
UC's Eric Vick receives major grants to advance research into combination therapy for leukemia

UC's Eric Vick receives major grants to advance research into combination therapy for leukemia

Breast cancer rises among Asian American and Pacific Islander women

Breast cancer rises among Asian American and Pacific Islander women

Weill Cornell Medicine secures $12.4 million grant for lymphoma research

Weill Cornell Medicine secures $12.4 million grant for lymphoma research

Study reveals a paradigm shift in the understanding of T-lineage acute lymphoblastic leukemia

Study reveals a paradigm shift in the understanding of T-lineage acute lymphoblastic leukemia

New trial explores BAFF CAR T-cell therapy for relapsed myeloma

New trial explores BAFF CAR T-cell therapy for relapsed myeloma

Exploring the distinct characteristics of Nodular Lymphocyte Predominant Hodgkin Lymphoma

Exploring the distinct characteristics of Nodular Lymphocyte Predominant Hodgkin Lymphoma

New advances in Hodgkin's lymphoma treatment offer hope for affected individuals

New advances in Hodgkin's lymphoma treatment offer hope for affected individuals

Study reveals how light-activated macrophages increase their appetite for cancer cells

Study reveals how light-activated macrophages increase their appetite for cancer cells

EZH2's role in cancer progression and therapy explored

EZH2's role in cancer progression and therapy explored

Review of fasting-mimicking diets in cancer treatment

Review of fasting-mimicking diets in cancer treatment

Small-town patients face big hurdles as rural hospitals cut cancer care

Small-town patients face big hurdles as rural hospitals cut cancer care

Quality-of-life measurements are essential in cancer care, study says

Quality-of-life measurements are essential in cancer care, study says

Anticancer drugs show promise in reducing Alzheimer's dementia risk

Anticancer drugs show promise in reducing Alzheimer's dementia risk

Loss of Gα13 in B-cells linked to increased lymphoma risk due to dietary glutamine

Loss of Gα13 in B-cells linked to increased lymphoma risk due to dietary glutamine

Researchers find the effect of pesticides on increased cancer risk is comparable to smoking for some cancers

Researchers find the effect of pesticides on increased cancer risk is comparable to smoking for some cancers

Moffitt study identifies predictive biomarkers for immunotherapy in merkel cell carcinoma

Moffitt study identifies predictive biomarkers for immunotherapy in merkel cell carcinoma

Montana looks to become latest state to boost nonprofit hospital oversight

Montana looks to become latest state to boost nonprofit hospital oversight

Study highlights infection as major post-CAR-T therapy challenge

Study highlights infection as major post-CAR-T therapy challenge

Pesticide use in agriculture may pose cancer risks similar to smoking

Pesticide use in agriculture may pose cancer risks similar to smoking

Researchers discover new target for treating diseases linked to T-cell leukemia virus type 1

Researchers discover new target for treating diseases linked to T-cell leukemia virus type 1

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.